6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
6m ago	ProWood TrueFrame Joist Now Available Across Northeast, South Atlantic
7m ago	Parker to Acquire CIRCOR’s Commercial and Defense Aerospace Business
7m ago	Toll Brothers Announces Cedar Terrace Community Now Open in Chantilly, Virginia
7m ago	When Blood Compatibility Becomes a Pregnancy Risk
7m ago	Tony and Grammy Award-Winning Leslie Odom, Jr. to Headline Blackbaud's bbcon 2026 Social Impact Tech Conference

About

1.04USD+0.03 +2.94%

Closed • Updated at 13:54 GMT+00:00

Market Cap$278.91M

Volume379.1K

Beta0.23

RSI37.08

Gross Margin80.46%

Health TechnologyPharmaceuticals: Major

Akebia Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Akebia Therapeutics Reports First Quarter 2026 Financial Results and Commercial and Pipeline Highlights

Akebia Therapeutics Announces Vadadustat Post-hoc Win Statistics Analysis Demonstrating Statistically Significant Reduction in Mortality and Hospitalization Composite Endpoint Published in the Journal of American Society of Nephrology

Akebia Therapeutics to Report First Quarter 2026 Financial Results and Discuss Recent Business Highlights

Akebia Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of AKB-9090

Akebia Therapeutics to Conduct Investor Meetings at the Raymond James 2026 Biotech Innovation Symposium

Community Chat

Ask AI